Delivery Order SPE2DB22D1103-SPE2DB24FTRY3

Award Date 9/24/24
Potential Completion Date 9/25/24
Potential Value $1.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $1,222.39 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of ATOVAQUONE-PROGUANIL 250-100 100S, a medical commodity used for infectious disease prevention. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical,...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4,568,173,842 units of the pharmaceutical product Atovaquone-Proguanil 250-100 100s. The delivery order has a ceiling value of $1,160.03 and is a firm fixed-price contract. This award is not a set-aside and is part of a larger Indefinite Delivery Contract (IDC) that...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,164.42, is for the delivery of ATOVAQUONE-PROGUANIL 250-100 100S, a pharmaceutical product. This is a delivery order contract with a firm fixed price pricing type. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp is the prime contractor and the ultimate completion date...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4567197863 - ATOVAQUONE-PROGUANIL 250-100 100S, a pharmaceutical product, with a ceiling value of $11,671.59 and a completion date of February 10, 2025. The contract is a firm fixed price Delivery Order under an Indefinite Delivery Contract (IDC) vehicle with the DLA Troop...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of ATOVAQUONE-PROGUANIL 250-100 100S, a pharmaceutical product, with a ceiling value of $1,478.61 and a period of performance through June 24, 2025. The contract is not set aside and represents an open competition award. Amerisourcebergen Drug Corp holds a significant...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,234.23, is for the delivery of Atovaquone-Proguanil 250-100 100S, a pharmaceutical product. The contract has a firm fixed price pricing type and an ultimate completion date of May 29, 2024. This appears to be a delivery order under a larger Indefinite Delivery Contract...
This $11,684.52 firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The order is for 4,565,384,970 units of Atovaquone-Proguanil 250-100 100S, a prescription anti-malarial medication. This delivery order is part of a larger indefinite delivery contract (IDC) valued up to $999,999,999 between Amerisourcebergen and DLA Troop Support Medical, which provides a comprehensive range of medical...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,367.21 firm fixed-price contract is for the delivery of ATOVAQUONE-PROGUANIL 250-100 100S, a pharmaceutical product. The award has a performance period ending on May 19, 2025. Amerisourcebergen Drug Corp is the prime contractor, and the contract is not set-aside. The company holds a significant Indefinite Delivery...
This is a delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the provision of ATOVAQUONE-PROGUANIL 250-100 100S medication. The contract has a firm fixed price of $2,574.39 and a period of performance through July 2, 2025. The contract is not designated as a set-aside and is an open competition award. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order under a larger Indefinite Delivery Contract (IDC) awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $2,470.75 firm fixed price delivery order is for Atovaquone-Proguanil 250-100 100s, a malaria medication. The contract has a completion date of May 16, 2024 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 IDC with DLA...
  • SPE2DB22D1103
    Indefinite Delivery Contract
  • SPE2DB22D1103-SPE2DB24FTRY3
    Delivery Order

This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,583.46 firm-fixed-price contract is for the supply of ATOVAQUONE-PROGUANIL 250-100 100S, a pharmaceutical product. The delivery order was issued under an Indefinite Delivery Contract (IDC) between DLA Troop Support Medical and Amerisourcebergen, valued at up to $999,999,999 through December 2025, for the provision of a wide range of medical commodities to support military treatment programs and facilities worldwide. There is no set-aside designation for this contract award.

Generated 12/24/24, 9:20 AM